Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration


Creative Commons License

Okada M., Wong T. Y., Mitchell P., Eldem B., Talks S. J., Aslam T., ...More

JAMA OPHTHALMOLOGY, vol.139, pp.769-776, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 139
  • Publication Date: 2021
  • Doi Number: 10.1001/jamaophthalmol.2021.1660
  • Journal Name: JAMA OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.769-776
  • Hacettepe University Affiliated: Yes

Abstract

IMPORTANCE Poor adherence or persistence to treatment can be a barrier to optimizing clinical practice (real-world) outcomes to intravitreal injection therapy in patients with neovascular age-related macular degeneration (nAMD). Currently, there is a lack of consensus on the definition and classification of adherence specific to this context.